These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 16061467)

  • 1. Model policy for the use of controlled substances for the treatment of pain.
    Federation of State Medical Boards of the United States, Inc
    J Pain Palliat Care Pharmacother; 2005; 19(2):73-8. PubMed ID: 16061467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Federal and state regulation of opioids.
    Joranson DE
    J Pain Symptom Manage; 1990 Feb; 5(1 Suppl):S12-23. PubMed ID: 1969888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. State medical board members' beliefs about pain, addiction, and diversion and abuse: a changing regulatory environment.
    Gilson AM; Maurer MA; Joranson DE
    J Pain; 2007 Sep; 8(9):682-91. PubMed ID: 17627894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. State medical board members' attitudes about the legality of chronic prescribing to patients with noncancer pain: the influence of knowledge and beliefs about pain management, addiction, and opioid prescribing.
    Gilson AM
    J Pain Symptom Manage; 2010 Oct; 40(4):599-612. PubMed ID: 20656452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines.
    Trescot AM; Helm S; Hansen H; Benyamin R; Glaser SE; Adlaka R; Patel S; Manchikanti L
    Pain Physician; 2008 Mar; 11(2 Suppl):S5-S62. PubMed ID: 18443640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid analgesics for pain control: wisconsin physicians' knowledge, beliefs, attitudes, and prescribing practices.
    Wolfert MZ; Gilson AM; Dahl JL; Cleary JF
    Pain Med; 2010 Mar; 11(3):425-34. PubMed ID: 20002590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for selecting treatment and mitigating risk in patients with chronic pain.
    Fishman SM
    J Clin Psychiatry; 2011 Jan; 72(1):e02. PubMed ID: 21272509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kentucky Board of Medical Licensure. Model guidelines for the use of controlled substances in pain treatment.
    J Ky Med Assoc; 2001 Jul; 99(7):291-4. PubMed ID: 11468871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pain management: a regulatory issue.
    Brekken SA; Sheets V
    Nurs Adm Q; 2008; 32(4):288-95. PubMed ID: 18813085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. State policy affecting pain management: recent improvements and the positive impact of regulatory health policies.
    Gilson AM; Maurer MA; Joranson DE
    Health Policy; 2005 Oct; 74(2):192-204. PubMed ID: 16153479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997-2002.
    Gilson AM; Ryan KM; Joranson DE; Dahl JL
    J Pain Symptom Manage; 2004 Aug; 28(2):176-88. PubMed ID: 15276196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do international model drug control laws provide for drug availability?
    University of Wisconsin Pain & Policy Studies Group
    J Pain Palliat Care Pharmacother; 2009; 23(2):145-52. PubMed ID: 19492215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving state pain policies: recent progress and continuing opportunities.
    Gilson AM; Joranson DE; Maurer MA
    CA Cancer J Clin; 2007; 57(6):341-53. PubMed ID: 17989129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The barriers to adequate pain management with opioid analgesics.
    Hill CS
    Semin Oncol; 1993 Apr; 20(2 Suppl 1):1-5. PubMed ID: 8097339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prosecution of physicians for prescribing opioids to patients.
    Reidenberg MM; Willis O
    Clin Pharmacol Ther; 2007 Jun; 81(6):903-6. PubMed ID: 17329989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Medical Examining Board speaks on pain management: everyone should listen.
    Hargus E; Trotta P; Gilson A; Russell DR; Dinnan MS
    Conn Med; 2005 Sep; 69(8):485-91. PubMed ID: 16270783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pain management and the use of controlled substances: is a "standard of practice" standard practice?
    Gilson AM
    Pain Med; 2009 Apr; 10(3):562-3; discussion 564. PubMed ID: 19416441
    [No Abstract]   [Full Text] [Related]  

  • 18. Failure of enforcement controlled substance laws in health policy for prescribing opiate medications: a painful assessment of morbidity and mortality.
    Miller NS
    Am J Ther; 2006; 13(6):527-33. PubMed ID: 17122534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The DEA's Balancing Act to Ensure Public Health and Safety.
    Rannazzisi JT
    Clin Pharmacol Ther; 2007 Jun; 81(6):805-6. PubMed ID: 17505495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doctors, opioids, and the law: the effect of controlled substances regulations on cancer pain management.
    Weissman DE
    Semin Oncol; 1993 Apr; 20(2 Suppl 1):53-8. PubMed ID: 7682731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.